News
-
Scheme document published for the £35.6 million recommended acquisition of STM Group by The Pension Superfund
November 2023
-
Adsure Services float on the Aquis Growth Market
October 2023
-
Offer document published for unconditional mandatory cash offer for Allergy Therapeutics by ZQ Capital with a valuation of £48 million
October 2023
-
Redx Pharma conditionally raises £14.1 million via a subscription of shares from existing investors
October 2023
-
Scheme document published for the £30.8 million recommended cash acquisition of Smoove by Pexa
October 2023
-
Perivan clients are winners in 5 different categories at the AIM Awards 2023
October 2023
-
Scheme document published for the £203 million recommended cash acquisition of Instem by ARCHIMED SAS
September 2023
-
Scheme document published for the $469 million recommended cash acquisition of Round Hill Music Royalty Fund by Concord Cadence
September 2023
-
Scheme document published for the £703 million recommended cash acquisition of Ergomed by Permira
September 2023
-
Perivan welcomes Hargreaves Services to our Annual Report portfolio
September 2023
-
Perivan clients are winners in 4 different AIC categories
September 2023
-
Scheme document published for the £3.11 million recommended cash acquisition of Osirium Technologies by Sailpoint Technologies
September 2023
-
Perivan produce Direct Mail Campaign for World Cancer Research Fund
September 2023
-
Tribe Technology float on AIM
September 2023
-
Nippon Active Value Fund publish Scheme of Reconstruction prospectus
September 2023
-
Perivan welcomes Quiz to our Annual Report portfolio
August 2023
